17 / 1020
Symposium with Proffered Papers
Plan of the day (PotD): current status (Abs. 619-621)
Debate
We don’t need better dose calculation, it’s doing more bad than
good (Abs. 622-623)
Are we precisely inaccurate in our adaption? (Abs. 624-625)
Moving away from 2 Gray: are we ready for a paradigm shift? (Abs.
626-629)
Posters
Clinical track: Head and neck (Abs. 630-640)
Clinical track: CNS (Abs. 641-661)
Clinical track: Haematology (Abs. 662-671)
Clinical track: Breast (Abs. 672-677)
Clinical track: Lung (Abs. 678-695)
Clinical track: Upper GI (oesophagus, stomach, pancreas, liver)
(Abs. 696-714)
Clinical track: Lower GI (colon, rectum, anus) (Abs. 715-722)
Clinical track: Gynaecological (endometrium, cervix, vagina, vulva)
(Abs. 723-735)
Clinical track: Prostate (Abs. 736-758)
Clinical track: Urology-non-prostate (Abs. 759-760)
Clinical track: Skin cancer / malignant melanoma (Abs. 761-763)
Clinical track: Sarcoma (Abs. 764-768)
Clinical track: Paediatric tumours (Abs. 769-771)
Clinical track: Palliation (Abs. 772-779)
Clinical track: Elderly (Abs. 780-782)